US Health and Human Services unveils action plan to address ‘maternal morbidity,’ reduce racial disparities

Keelee Moseley knew something wasn’t right. After an emergency cesarean section in February 2018, the Texas mom was in so much pain she couldn’t walk. She told doctors she wasn’t feeling well. Still, hospital staff sent her home. In the following days, she only felt worse. Her heart rate rose, she nursed a fever and […]

Continue Reading

Pembrolizumab slows MSI-H-dMMR metastatic CRC

For the first-line treatment of microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal cancer, pembrolizumab is superior to chemotherapy for prolonging progression-free survival, according to a study published in the Dec. 3 issue of the New England Journal of Medicine. Thierry André, M.D., from Sorbonne Université and Hôpital Saint Antoine in Paris, and colleagues conducted a […]

Continue Reading

Clinical trial results address concerns about pharmacogenetic testing

A person’s genetic make-up can influence whether they might experience side effects from certain medications. Some laboratories now offer pharmacogenetic tests that allow patients to learn whether they carry genetic variants known to be associated with adverse drug effects. Such tests might help patients and their doctors choose safer, more effective treatments, but the U.S. […]

Continue Reading